Log in to save to my catalogue

Ligustrazine monomer against cerebral ischemia/ reperfusion injury

Ligustrazine monomer against cerebral ischemia/ reperfusion injury

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_885011d2acd947929edb6238cceaaabb

Ligustrazine monomer against cerebral ischemia/ reperfusion injury

About this item

Full title

Ligustrazine monomer against cerebral ischemia/ reperfusion injury

Publisher

India: Medknow Publications and Media Pvt. Ltd

Journal title

Neural regeneration research, 2015-05, Vol.10 (5), p.832-840

Language

English

Formats

Publication information

Publisher

India: Medknow Publications and Media Pvt. Ltd

Subjects

Subjects and topics

More information

Scope and Contents

Contents

Ligustrazine (2,3,5,6-tetramethylpyrazine) is a major active ingredient of the Szechwan lovage rhizome and is extensively used in treatment of ischemic cerebrovascular disease. The mecha- nism of action of ligustrazine use against ischemic cerebrovascular diseases remains unclear at present. This study summarizes its protective effect, the optimum...

Alternative Titles

Full title

Ligustrazine monomer against cerebral ischemia/ reperfusion injury

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_885011d2acd947929edb6238cceaaabb

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_885011d2acd947929edb6238cceaaabb

Other Identifiers

ISSN

1673-5374

E-ISSN

1876-7958

DOI

10.4103/1673-5374.156991

How to access this item